Phoenix Bio





11月9日(金)~13日(火)にMoscone North and South Convention Center (アメリカのサンフランシスコ)で開催されます

The Liver Meeting 2018(AASLD)にて、PXBマウス・PXB-cells関連研究発表、ブース展示があります。

ポスター発表 (会場:Hall C-Poster Hall)

■セッション HBV: New and Approved Therapeies

発表日:11月9日(金) 8:00-17:30(Presentation time:Noon-13:30)


演題:Promising Antiviral Combination Therapy Targeting HBV Eradication with Nucleoside Analogue, Interferon, Statin,

and a Novel Compound Derived from Spice

発表者:Dr. Kazuya Okushin (Department of Infection Control and Prevention, The University of Tokyo)

■セッション Hepatitis B:Viology, Pathogenesis, and Immunology

発表日:11月9日(金) 8:00-17:30(Presentation time:Noon-13:30)


演題:Regulation of the Hepatitis B Virus Gene Expression and Replication By the Multi-Functional Protein Tardbp
発表者:Dr. Grace Naswa Makokha (Institute of Biomedical & Health Science, Hiroshima University)


演題:Liver Fibrosis Induced By Gut Microbes in Chimeric Mice Model with Human Hepatocytes Persistently Infected with

Hepatitis B Virus

発表者:Dr Masaya Sugiyama (Genome Medical Science Project, National Center for Global Health and Medicine)

■セッション Hepatitis C Therapeutics:Approved Agents

発表日:11月9日(金) 8:00-17:30(Presentation time:Noon-13:30)


演題:Prevalence of NS5A Resistance Associated Variants in NS5A Inhibitor Treatment Failures and an Effective

Treatment for NS5A-P32 Deleted Hepatitis C Virus in Humanized Mice

発表者:Dr. Yuji Teraoka (Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical &

Health Science, Hiroshima University)


演題:Efficacy of Glecaprevir and Pibrentasvir Treatment for Hepatitis C Virus Drug Resistance-Associated Variants in

Humanized Mice

発表者:Dr. Mitsutaka Osawa (Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science,

Hiroshima University)

■セッション Hepatitis C:Virology, Pathogenesis and Immunology

発表日:11月10日(土) 14:00-19:30(Presentation time:17:30-19:00)


演題:A Novel Jak3KORag2KO Chimeric Mouse Model for the Study of Hepatitis Virus Virology
発表者:Dr. Takuro Uchida (Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science,

Hiroshima University)

■セッション Liver Fibrogenesis and Non-Parenchymal Cell Biology

発表日:11月10日(土) 14:00-19:30(Presentation time:17:30-19:00)


演題:Screening of Pharmaceuticals for Their Effectiveness in Preventing Liver Fibrosis Using Mice with Humanized Livers,

with an Assessment of the Therapeutic Effect Using Mouse Liver Fibrosis Models

発表者:Dr. Norihiro Sakai (Division of Gastroenterology and Hepatology, Niigata University)

■セッション Pediatric Hapatology

発表日:11月11日(日) 8:00-17:30(Presentation time:12:30-14:00)


演題:Development of Human Ornithine Transcabamylase Deficiency Model Using cDNA-uPA/SCID Chimeric Mice with

Patient Hepatocytes

発表者:Chise Tateno (R&D Department, Phoenixbio Co., Ltd.)

■セッション Clinical and Translational Fibrosis Research

発表日:11月11日(日) 8:00-17:30(Presentation time:12:30-14:00)


演題:The Role of TLL1 in Hepatic Fibrogenesis and Carcinogenesis
発表者:Dr. Kentaro Matsuura (Department of Gastroenterology and Metabolism, Nagoya City University Graduate School

of Medical Sciences)


ブース# 542 (Exhibit Hall)


2018年11月10日(土)    17:00 – 19:30 (Exhibit Hall Opening Reception)
2018年11月11日(日)    9:30 – 15:00
2018年11月12日(月)    9:30 – 15:00